Fluoxetine for the treatment of onychotillomania associated with obsessive-compulsive disorder: a case report
- PMID: 36403006
- PMCID: PMC9675954
- DOI: 10.1186/s13256-022-03652-9
Fluoxetine for the treatment of onychotillomania associated with obsessive-compulsive disorder: a case report
Abstract
Background: Obsessive-compulsive disorder is a condition in which patients experience an obsession and/or a compulsion. It has a high impact on the quality of life, and is associated with an increased prevalence of psychiatric comorbidities in patients. Onychotillomania is an underestimated psychodermatosis caused by repeated self-inflicted damage to the nail unit. In patients, it is characterized by an obsessive or irrepressible impulse to repeatedly damage their own nails, resulting in their destruction. It is a chronic condition that is difficult to manage, largely because of its psychocutaneous character, as well as its high tendency to interact with underlying neuropsychiatric diseases or other behavioral disorders. Only a few studies have reported an association between obsessive-compulsive disorder and onychotillomania, which typically presents with therapeutic challenges. Cognitive behavioral therapy, physical-barrier approaches, and pharmaceutical treatments have been reported to be beneficial in the management of onychotillomania; however, no major clinical studies have investigated the effectiveness of these therapies. Onychotillomania remains a clinical and therapeutic issue owing to the lack of evidence-based treatment techniques.
Case presentation: We report a case of an 18-year-old, middle-eastern female patient who developed onychotillomania when she was being treated with paroxetine for obsessive-compulsive disorder and was showing partial improvement. The patient developed side effects from paroxetine, and was switched to fluoxetine. Thereafter, improvement in her obsessive-compulsive disorder was observed, which relapsed when treatment was discontinued. However, the onychotillomania symptoms did not reemerge.
Conclusion: Onychotillomania typically presents both diagnostic and therapeutic challenges. Fluoxetine plays an important role in the treatment of onychotillomania and other psychiatric disorders. However, large-scale studies should be conducted before these outcomes can be generalized.
Keywords: Fluoxetine; Focused body repetitive behavior; Nail tic disorders; Obsessive–compulsive disorder; Onychotillomania; Paroxetine.
© 2022. The Author(s).
Conflict of interest statement
The author has no conflict of interest to declare.
Figures
Similar articles
-
Onychotillomania in the Setting of Homelessness.Cureus. 2022 Mar 9;14(3):e22988. doi: 10.7759/cureus.22988. eCollection 2022 Mar. Cureus. 2022. PMID: 35415028 Free PMC article.
-
Onychotillomania: A Chameleon-Like Disorder: Case Report and Review of Literature.Skin Appendage Disord. 2019 Feb;5(2):104-107. doi: 10.1159/000489941. Epub 2018 Jun 25. Skin Appendage Disord. 2019. PMID: 30815444 Free PMC article.
-
Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results.Arch Gen Psychiatry. 1990 Oct;47(10):926-32. doi: 10.1001/archpsyc.1990.01810220042005. Arch Gen Psychiatry. 1990. PMID: 2222131 Clinical Trial.
-
Effectiveness of paroxetine in the treatment of obsessive-compulsive disorders.Expert Rev Neurother. 2006 Jul;6(7):945-56. doi: 10.1586/14737175.6.7.945. Expert Rev Neurother. 2006. PMID: 16831110 Review.
-
[Value of fluoxetine in obsessive-compulsive disorder in the adult: review of the literature].Encephale. 2001 May-Jun;27(3):280-9. Encephale. 2001. PMID: 11488259 Review. French.
References
-
- Asken MJ, Grossman D, Christensen LW, American Psychiatric Association . Diagnostic and statistical manual of mental disorders. Arlington: American Psychiatric Publishing; 2013.
-
- Dell’Osso B, Benatti B, Arici C, Palazzo C, et al. Prevalence of suicide attempt and clinical characteristics of suicide attempters with obsessive–compulsive disorder: a report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS) CNS Spectr. 2018;23:59–66. doi: 10.1017/S1092852917000177. - DOI - PubMed
-
- NIMH. Obsessive–compulsive disorder; 2019. https://www.nimh.nih.gov/health/topics/obsessive-compulsive-disorder-ocd. Accessed Feb 2022
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical